Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 56 15
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 50 20
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Sotrovimab Emergency use authorization Experimental Antiviral Aug/26/2022 9 5
REGEN-COV Emergency use authorization Experimental Antiviral Aug/02/2022 21 4
Nirmatrelvir Emergency use authorization Experimental Antiviral Jul/04/2022 8 0
N(4)-Hydroxycytidine Potential treatment - pre-clinical evidence Experimental Antiviral Jul/04/2022 6 0
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/04/2022 11 1
Excel (.xslx) CSV (.csv)